NR1H4 and Hepatic steatosis: Under the intervention of an HFD, the GM promotes weight gain and liver steatosis in an FXR-dependent manner, and the improvement of hepatic steatosis associated with antibiotic therapy depends on FXR signal transduction (Jiang et al., 2015; Parseus et al., 2017).